Xiang B - Search Results

1

Carotid I's, L's and T's: collaterals shape the outcome of intracranial carotid occlusion in acute ischemic stroke.

Liebeskind DS, Flint AC, Budzik RF, Xiang B, Smith WS, Duckwiler GR, Nogueira RG; MERCI and Multi-MERCI Investigators. Liebeskind DS, et al. Among authors: xiang b. J Neurointerv Surg. 2015 Jun;7(6):402-7. doi: 10.1136/neurintsurg-2014-011231. Epub 2014 May 1. J Neurointerv Surg. 2015. PMID: 24789707 Free PMC article.

2

Predictors of functional dependence despite successful revascularization in large-vessel occlusion strokes.

Shi ZS, Liebeskind DS, Xiang B, Ge SG, Feng L, Albers GW, Budzik R, Devlin T, Gupta R, Jansen O, Jovin TG, Killer-Oberpfalzer M, Lutsep HL, Macho J, Nogueira RG, Rymer M, Smith WS, Wahlgren N, Duckwiler GR; Multi MERCI, TREVO, and TREVO 2 Investigators. Shi ZS, et al. Among authors: xiang b. Stroke. 2014 Jul;45(7):1977-84. doi: 10.1161/STROKEAHA.114.005603. Epub 2014 May 29. Stroke. 2014. PMID: 24876082 Free PMC article.

3

Periprocedural heparin use in acute ischemic stroke endovascular therapy: the TREVO 2 trial.

Winningham MJ, Haussen DC, Nogueira RG, Liebeskind DS, Smith WS, Lutsep HL, Jovin TG, Xiang B, Nahab F. Winningham MJ, et al. Among authors: xiang b. J Neurointerv Surg. 2018 Jul;10(7):611-614. doi: 10.1136/neurintsurg-2017-013441. Epub 2017 Oct 31. J Neurointerv Surg. 2018. PMID: 29089415 Clinical Trial.

4

Collateral Circulation in Thrombectomy for Stroke After 6 to 24 Hours in the DAWN Trial.

Liebeskind DS, Saber H, Xiang B, Jadhav AP, Jovin TG, Haussen DC, Budzik RF, Bonafe A, Bhuva P, Yavagal DR, Hanel RA, Ribo M, Cognard C, Sila C, Hassan AE, Smith WS, Saver JL, Nogueira RG; DAWN Investigators. Liebeskind DS, et al. Among authors: xiang b. Stroke. 2022 Mar;53(3):742-748. doi: 10.1161/STROKEAHA.121.034471. Epub 2021 Nov 3. Stroke. 2022. PMID: 34727737 Clinical Trial.

5

THRIVE score predicts outcomes with a third-generation endovascular stroke treatment device in the TREVO-2 trial.

Flint AC, Xiang B, Gupta R, Nogueira RG, Lutsep HL, Jovin TG, Albers GW, Liebeskind DS, Sanossian N, Smith WS; TREVO-2 Trialists. Flint AC, et al. Among authors: xiang b. Stroke. 2013 Dec;44(12):3370-5. doi: 10.1161/STROKEAHA.113.002796. Epub 2013 Sep 26. Stroke. 2013. PMID: 24072003 Free PMC article. Clinical Trial.

6

Pittsburgh response to endovascular therapy score as a pre-treatment prognostic tool: External validation in Trevo2.

Ali Raza S, Xiang B, Jovin TG, Liebeskind DS, Shields R, Nogueira RG, Rangaraju S; Trevo2 study group. Ali Raza S, et al. Among authors: xiang b. Int J Stroke. 2017 Jul;12(5):494-501. doi: 10.1177/1747493016677984. Epub 2016 Jan 1. Int J Stroke. 2017. PMID: 27811307 Clinical Trial.

7

Serial ASPECTS in the DAWN Trial: Infarct Evolution and Clinical Impact.

Liebeskind DS, Saber H, Bhuva P, Xiang B, Yoo AJ, Jadhav AP, Haussen DC, Budzik RF, Bonafe A, Yavagal DR, Hanel RA, Ribo M, Cognard C, Sila C, Hassan AE, Smith WS, Saver JL, Nogueira RG, Jovin TG. Liebeskind DS, et al. Among authors: xiang b. Stroke. 2021 Oct;52(10):3318-3324. doi: 10.1161/STROKEAHA.120.033477. Epub 2021 Jul 20. Stroke. 2021. PMID: 34281376

8

Stagnation of treatment times over a decade: results of a pooled analysis from the MERCI registry, MERCI, TREVO, and TREVO 2 trials.

Gupta R, Xiang B, Ge S, Sun CH, Yoo AJ, Mehta BP. Gupta R, et al. Among authors: xiang b. J Neurointerv Surg. 2016 May;8(5):453-6. doi: 10.1136/neurintsurg-2014-011626. Epub 2015 Mar 24. J Neurointerv Surg. 2016. PMID: 25805755

9

Optical spin hall effect in exciton-polariton condensates in lead halide perovskite microcavities.

Xiang B, Li Y, Spencer MS, Dai Y, Bai Y, Basov DN, Zhu XY. Xiang B, et al. J Chem Phys. 2024 Apr 28;160(16):161104. doi: 10.1063/5.0202341. J Chem Phys. 2024. PMID: 38661194

10

CircCDYL2 bolsters radiotherapy resistance in nasopharyngeal carcinoma by promoting RAD51 translation initiation for enhanced homologous recombination repair.

Qu H, Wang Y, Yan Q, Fan C, Zhang X, Wang D, Guo C, Chen P, Shi L, Liao Q, Zhou M, Wang F, Zeng Z, Xiang B, Xiong W. Qu H, et al. Among authors: xiang b. J Exp Clin Cancer Res. 2024 Apr 23;43(1):122. doi: 10.1186/s13046-024-03049-0. J Exp Clin Cancer Res. 2024. PMID: 38654320

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

1,437 results

Search Page